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ABSTRACT 
By 2020, non-communicable diseases including cardiovascular diseases (CVD) are expected 
to account for seven out of every 10 deaths in the developing countries compared with less 
than half this value today. As a proportion of total deaths from all-causes, CVD in the Asia–
Pacific region ranges from less than 20% in countries such as Thailand, Philippines and 
Indonesia to 20–30% in urban China, Hong Kong, Japan, Korea and Malaysia. Countries 
such as New Zealand, Australia and Singapore have relatively high rates that exceed 30–
35%. The latter countries also rank high for coronary heart disease (CHD) mortality rate 
(more than 150 deaths per 100 000). In contrast, death from cerebrovascular disease is higher 
among East Asian countries including Japan, China and Taiwan (more than 100 per 100 000). 
It is worth noting that a number of countries in the region with high proportions of deaths 
from CVD have undergone marked declining rates in recent decades. For example, in 
Australia, between 1986 and 1996, mortality from CHD in men and women aged 30–69 years 
declined by 46 and 51%, respectively. In Japan, stroke mortality dropped from a high level of 
150 per 100 000 during the 1920s–1940s to the present level of approximately 100 per 100 
000. Nonetheless, CVD mortality rate is reportedly on the rise in several countries in the 
region, including urban China, Malaysia, Korea and Taiwan. In China, CVD mortality 
increased as a proportion of total deaths from 12.8% in 1957 to 35.8% in 1990. The region is 
undergoing a rapid pace of urbanization, industrialization and major technological and 
lifestyle changes. Thus, monitoring the impact of these changes on cardiovascular risks is 
essential to enable the implementation of appropriate strategies towards countering the rise of 
CVD mortality. 
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